SANOFI ONCOLOGY

Sanofi's focus on patients has driven our historical and ongoing strategy to create long-term value by researching and delivering innovative treatments. Sanofi Oncology's heritage in oncology has given us an extensive knowledgebase that enriches our current research expertise. This experience encompasses a wide variety of cancer types, disease stages, patient populations, and patient needs. As a global healthcare company focused on patient needs, they are committed to attacking cancer on many fronts.
SANOFI ONCOLOGY
Industry:
Biotechnology Health Care
Founded:
1950-01-01
Address:
Bridgewater, New Jersey, United States
Country:
United States
Website Url:
http://www.sanofioncology.com
Total Employee:
1+
Status:
Active
Contact:
336-407-4994
Technology used in webpage:
Domain Not Resolving ASP.NET Ajax
Similar Organizations
Atrapos Therapeutics
Atrapos Therapeutics specializes in developing therapeutic solutions for auto-immune disorders.
Opulus
Opulus developes and integrates technology for pharmaceutical industry.
Official Site Inspections
http://www.sanofioncology.com
- Host name: ec2-54-247-151-159.eu-west-1.compute.amazonaws.com
- IP address: 54.247.151.159
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02

More informations about "Sanofi Oncology"
Our Medicines: Oncology - Sanofi
World Health Organization (2022) Cancer. Accessed October 2022; European Commission (2022). EU Science Hub. European Cancer Information System: 21% increase in new cancer โฆSee details»
Oncology - Sanofi
A cancer diagnosis carries incredible burdens. Thatโs why we pursue new therapies, work to help expand access to medicines, provide support, and learn from patients every day.See details»
Sanofi Oncology - Crunchbase Company Profile & Funding
Www.sanofioncology.com ; 972,440; Highlights. ... Sub-Organization of . Sanofi . Founded Date Aug 2012; Operating Status Active; Company Type For Profit; Phone Number 336-407-4994; โฆSee details»
Sanofi to present oncology strategy, provide update on portfolio โฆ
Jun 2, 2005 Sanofi to present oncology strategy, provide update on portfolio and emerging pipeline . PARIS โ April 2, 2020 โ Sanofi Chief Executive Officer Paul Hudson along with R&D โฆSee details»
Sanofi Oncology Company Profile | Management and Employees โฆ
Www.sanofioncology.com . Sanofi Oncology Profile and History. Sanofi's focus on patients has driven our historical and ongoing strategy to create long-term value by researching and โฆSee details»
Sanofi Oncology - PitchBook
Sanofi Oncology General Information Description. Operator of a cancer-drug development company. The company develops treatments for refractory chronic lymphocytic leukemia, as โฆSee details»
Sanofi - Clinical Operations - The Org
The Clinical Operations team at Sanofi plays a crucial role in the planning, execution, and management of clinical trials across various therapeutic areas, including oncology and vaccines.See details»
Sanofi Oncology Logo & Brand Assets (SVG, PNG and vector ...
Find the Sanofi Oncology style guide with brand assets such as logos, colors, fonts, and more.See details»
Oncology - Sanofi
Our immuno-oncology, molecular oncology, and innate cell therapy teams are pursuing a range of novel targeted therapies. We look for partnerships that complement our efforts in non โฆSee details»
A Conversation With Sanofiโs Olivier Nataf on
Dec 11, 2023 Did you know nearly 1.3 million cases of blood cancer are diagnosed worldwide each year?1 | An inside look at Sanofiโs approach to hematology R&D: Q&A with new Global Head of Oncology, Olivier ...See details»
Our Oncology R&D: Finding Cancer โฆ
LaMarche MJ (2022) Think Biologically, Act Chemically. J Medicinal Chem; DOI: 10.1021/acs.jmedchem.2c01121; Manandhar M, Chun E, Romesberg FE (2021) Genetic Code ...See details»
New data from Sanofiโs diverse, differentiated oncology pipeline โฆ
Jun 2, 2023 Oral presentation to highlight results of a first-in-human study of an investigational trifunctional anti-CD123 NK cell engager SAR443579, which was recently granted Fast Track โฆSee details»
Sanofi creates diverse pathways to success - The Globe and Mail
Dec 3, 2024 โThe support around diversity, equity and inclusion has really grown since Iโve been with the company,โ confirms Kim, who on top of her work duties co-leads a multicultural โฆSee details»
Sanofi (SNY) Company Profile & Facts - Yahoo Finance
See the company profile for Sanofi (SNY) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives โฆSee details»
Sanofi Pharmaceuticals - Healthcare Innovations | Sanofi USA
Feb 18, 2025 Sanofi colleagues share their personal experiences living with, or caring for someone living with, a rare disease. Hear some of their thoughts, hopes, and challenges, from โฆSee details»
A Leading Immunology Healthcare Company | Sanofi
3 days ago Your Health. March 7, 2025. MMoving Forward: Sparking Change in Multiple MyelomaSee details»
Best Practice Spotlight Organizations (BPSO) - RNAO.ca
The Best Practice Spotlight Organization® (BPSO®) designation is a longstanding knowledge translation strategy that helps optimize health outcomes at the individual, organizational and โฆSee details»
Sanofi Rare Blood Disorders
Find information, support, and resources for those impacted by rare blood disorders such as hemophilia A and B and acquired thrombotic thrombocytopenic purpura (aTTP).See details»
Our Company: Innovating Healthcare to Improve Lives | Sanofi
Sanofi, a global healthcare company, turns the impossible into possible by discovering, developing, and delivering medicines and vaccines to improve lives.See details»
Capital Ovarian Cancer Organization
Sep 17, 2019 The Capital Ovarian Cancer Organization (C.O.C.O.) is a non-profit organization that offers support services for women and families fighting ovarian cancer. Our goals are to โฆSee details»